MOHAP Product Registration UAE: EDE Compliance Guide

Is MOHAP product registration UAE still the correct route? Learn how EDE classification, marketing authorization, documents and compliance now work.

8/26/20269 min read

MOHAP product registration UAE transition to EDE for medical product compliance
MOHAP product registration UAE transition to EDE for medical product compliance

MOHAP Product Registration UAE: Quick Answer

Reviewed by: Product Registration UAE Regulatory Team – Medical Products and Market Access

MOHAP product registration UAE remains a widely used search term for pharmaceutical, medical-device, supplement and healthcare-product approvals.

However, the current federal regulatory pathway for medical products is administered through the Emirates Drug Establishment (EDE) rather than the previous MOHAP registration structure.

Depending on its classification, a product may require:

  • An EDE medical-product classification letter

  • Registration of the marketing authorization holder

  • Registration of the manufacturing site

  • Marketing authorization for a drug or biopharmaceutical product

  • Marketing authorization for a healthcare product

  • Marketing authorization for a medical device

  • Supporting testing, analysis or pharmacovigilance requirements

  • Approval for subsequent variations, renewals or advertising

Not every supplement, cosmetic or wellness product automatically belongs under EDE. The correct route depends on the product’s composition, presentation, intended use, claims and mechanism of action.

Businesses should therefore confirm classification before preparing a registration dossier or appointing an applicant.

Does MOHAP Still Handle Medical Product Registration?

The UAE established the Emirates Drug Establishment under Federal Decree-Law No. 28 of 2023.

EDE now provides the federal regulatory services used for the classification, registration and marketing authorization of medical products within its scope.

These include pathways for:

  • Human pharmaceutical products

  • Biological and biopharmaceutical products

  • Healthcare products

  • Medical devices

  • Medical-product manufacturers

  • Marketing authorization holders

  • Product renewals and variations

  • Pharmaceutical and medical-product advertising

  • Post-market regulatory activities

References to “MOHAP registration” remain common because businesses, manufacturers and older documents may still use the former authority name.

For new applications, companies should verify the current service and submission channel through EDE instead of relying on an outdated MOHAP checklist or portal guide.

What Is EDE Medical-Product Classification?

Classification determines whether a product falls within EDE’s regulatory scope and which approval route applies.

EDE evaluates classification based on factors such as:

  • Product presentation

  • Composition

  • Intended use

  • Design

  • Claims

  • Mechanism of action

  • Dosage or method of administration

  • Target user

  • Product risk

A classification letter can identify whether the product requires EDE marketing authorization and the regulatory category under which it should be submitted.

This is particularly important for borderline products, including:

  • Dietary supplements

  • Herbal preparations

  • Medicated cosmetics

  • Antiseptics and disinfectants

  • Wellness products

  • Functional or fortified formulations

  • Software with a potential medical purpose

  • Products marketed with therapeutic claims

A product’s commercial name does not determine its regulatory category. A cosmetic-looking product can enter a medical-product pathway if its intended purpose or claims create a therapeutic function.

Conversely, not every vitamin, cosmetic or wellness product requires EDE marketing authorization.

Which Products May Require EDE Marketing Authorization?

Drugs and Biopharmaceutical Products

EDE provides a marketing-authorization pathway for conventional, biological and other human pharmaceutical products intended for importation and trade in the UAE.

This category may include:

  • Prescription medicines

  • Over-the-counter medicines

  • Biological products

  • Biopharmaceutical products

  • Certain herbal medicines

  • Other products classified as pharmaceutical products

The technical dossier must follow the applicable pharmaceutical requirements. EDE states that drug and biopharmaceutical submissions are prepared according to the electronic Common Technical Document, or eCTD, structure.

Healthcare Products

EDE describes healthcare products as preparations used for general human healthcare that are not intended to diagnose, treat, cure or prevent disease and do not require direct medical supervision when used.

Depending on classification, this pathway may cover:

  • Dietary supplements

  • Herbal products

  • Antiseptics and disinfectants

  • Medicated cosmetic preparations

  • Other eligible general healthcare products

The existence of this category does not mean every supplement or disinfectant must be registered through EDE. Formula, claims, presentation and intended use remain decisive.

Medical Devices

Medical devices intended for importation and trade may require EDE marketing authorization.

The assessment may consider:

  • Intended medical purpose

  • Device classification

  • Models and variants

  • Accessories

  • Manufacturing-site information

  • Quality-management certification

  • International conformity evidence

  • Safety and performance documentation

  • Instructions for use

  • Post-market surveillance information

Higher-risk products generally require more extensive evidence than lower-risk devices.

MOHAP Registration, EDE Classification and Marketing Authorization

These terms should not be used interchangeably.

Former MOHAP Registration

“MOHAP registration” is now primarily a legacy expression used to describe medical-product approval processes that were historically associated with the Ministry of Health and Prevention.

EDE Classification

Classification determines the regulatory category and whether EDE marketing authorization is required.

A classification letter does not itself authorize the product for commercial sale.

EDE Marketing Authorization

Marketing authorization is the product-specific approval issued after the applicable regulatory assessment has been completed.

It may depend on prior registration or licensing of the responsible companies, manufacturing sites and applicant.

Establishment and Manufacturer Registration

The legal manufacturer, marketing authorization holder or manufacturing site may require registration before the product application can proceed.

The product, applicant and manufacturing-site requirements must therefore be assessed together.

Who Can Submit an EDE Application?

Eligibility depends on the service.

EDE’s medical-product classification service is available to different applicant types, including companies and individuals.

However, product marketing-authorization applications generally require an eligible establishment, such as:

  • An EDE-licensed medical warehouse

  • A licensed local medical-product manufacturer

  • An eligible marketing office

  • Another applicant type specifically accepted for the selected service

Foreign manufacturers should not assume that they can submit every product application directly.

The UAE applicant structure, marketing authorization holder, manufacturer registration and authorization documents should be confirmed before dossier preparation begins.

How the EDE Product Registration Process Works

The exact sequence depends on the product category, but a controlled registration project generally follows these stages.

1. Confirm the Product Identity and Intended Use

The assessment should begin with a complete description of the product.

Review:

  • Product name

  • Composition or technical specifications

  • Dosage form or device type

  • Intended purpose

  • Target users

  • Directions for use

  • Product claims

  • Packaging presentation

  • Country-of-origin status

  • Existing international registrations

Unclear or conflicting product descriptions can lead to the wrong registration pathway.

2. Determine Whether Classification Is Required

Classification is particularly valuable when the product could fall between multiple categories.

Examples include:

  • Supplement versus conventional food

  • Healthcare product versus pharmaceutical product

  • Cosmetic versus medicated cosmetic

  • Consumer disinfectant versus medical product

  • General wellness software versus medical-device software

Submitting under the wrong category can result in rejection, rerouting or extensive dossier changes.

3. Confirm Applicant and Establishment Eligibility

Before preparing the product dossier, confirm:

  • Who will submit the application

  • Whether the applicant holds the required licence

  • Whether the marketing authorization holder is registered

  • Whether the manufacturing site is registered

  • Whether the local authorization or agency documents are valid

  • Whether company and manufacturer details are consistent

A technically complete product file cannot compensate for an ineligible applicant or unregistered manufacturing site.

4. Register the Manufacturing Site Where Required

EDE may require registration of the medical-product manufacturer before the product application.

Supporting evidence may include:

  • Valid manufacturing licence

  • Good Manufacturing Practice certificate

  • Site Master File

  • Product or production-line information

  • Quality-system certificates

  • Authorization documents

  • Existing international registrations

  • Manufacturing and contract-manufacturing details

Requirements vary according to whether the site manufactures pharmaceuticals, medical devices or other medical products.

5. Build the Product-Specific Technical Dossier

The dossier should be structured around the selected regulatory category.

Potential components include:

  • Application forms

  • Product formula or composition

  • Manufacturing-process information

  • Specifications and test methods

  • Certificate of Analysis

  • Stability data

  • Safety and performance evidence

  • Clinical or bioequivalence evidence where applicable

  • Quality and risk-management documents

  • Free Sale Certificate or Certificate of Pharmaceutical Product

  • Good Manufacturing Practice evidence

  • Product labelling and artwork

  • Instructions for use or patient information

  • International approval certificates

  • Pharmacovigilance documentation

  • Post-market surveillance information

Not every document applies to every product. The required file should be determined by classification and the selected EDE service.

6. Validate the UAE Label and Artwork

The label must agree with the technical dossier and approved product information.

Checks may include:

  • Product and brand name

  • Dosage form or device identity

  • Active and inactive ingredients

  • Intended use

  • Instructions for use

  • Dosage or administration information

  • Warnings and precautions

  • Contraindications

  • Storage conditions

  • Manufacturer details

  • Marketing authorization holder details

  • Batch and date information

  • Pack size

  • Arabic information where required

  • Claims and promotional wording

The label should be validated before commercial quantities are printed.

7. Submit Through the Applicable EDE Service

Applications are submitted through the current EDE digital service using the accepted account and applicant type.

The submission normally involves:

  • Accessing the applicable service

  • Completing the electronic application

  • Uploading the required documents

  • Paying the applicable fees

  • Responding to authority comments

  • Completing any required analysis or additional assessment

  • Receiving the final regulatory decision

The portal service selected must match the product’s confirmed classification.

8. Respond to Regulatory Queries

EDE may request clarification, replacement documents or additional evidence.

Common query subjects include:

  • Formula discrepancies

  • Unsupported claims

  • Unclear intended use

  • Missing manufacturer information

  • Inconsistent certificates

  • Incomplete stability evidence

  • Artwork differences

  • Incorrect product grouping

  • Missing authorizations

  • Insufficient safety or performance evidence

Responses should address the authority’s question directly and remain consistent with the rest of the dossier.

9. Complete Any Applicable Laboratory or Technical Evaluation

Testing or analysis is not identical for every product.

Depending on the category and regulatory assessment, requirements may involve:

  • Pharmaceutical analysis

  • Stability review

  • Bioequivalence assessment

  • Microbiological or chemical testing

  • Medical-device safety and performance evidence

  • Quality-control documentation

  • Additional product samples

Businesses should not assume that every product requires the same laboratory package or that any laboratory report will be accepted.

10. Receive and Review the Marketing Authorization

Following successful assessment, EDE may issue the applicable marketing authorization.

The business should verify:

  • Approved product name

  • Manufacturer

  • Marketing authorization holder

  • Product category

  • Models, variants or pack sizes

  • Authorization validity

  • Approved artwork or information

  • Conditions or limitations

  • Renewal requirements

Any discrepancy should be addressed before the authorization is used for importation or commercial activity.

Documents Commonly Required for EDE Registration

The exact list depends on the product, but commonly reviewed documents may include:

  • Valid applicant or establishment licence

  • Manufacturer registration evidence

  • Marketing authorization holder documents

  • Authorization or agency agreement

  • Manufacturing licence

  • Good Manufacturing Practice certificate

  • ISO 13485 certificate for relevant medical-device manufacturers

  • Certificate of Pharmaceutical Product

  • Certificate of Free Sale

  • Detailed formula or composition

  • Product specifications

  • Certificate of Analysis

  • Stability documentation

  • Safety and efficacy evidence

  • Clinical or bioequivalence data where applicable

  • Device conformity documents

  • Declaration of Conformity

  • Product catalogue

  • Risk classification

  • Post-market surveillance documents

  • Outer and inner packaging artwork

  • Instructions for use or product leaflet

  • Product photographs

  • Pharmacovigilance documentation

  • Evidence of registration in other markets

Certificates must apply to the actual product, manufacturer, site and formulation being submitted.

Common Reasons EDE Applications Are Delayed

Incorrect Product Classification

A product may be prepared as a supplement when its claims or ingredients place it in another category.

Applicant or Manufacturer Is Not Ready

The marketing authorization holder, applicant or manufacturing site may not hold the registration or licence required for the selected service.

Conflicting Product Information

Names, formulas, addresses, claims or pack details may differ across certificates, artwork and application forms.

Unsupported Therapeutic Claims

Claims can change a product’s classification and increase its evidence requirements.

Marketing language should be reviewed before submission and before commercial use.

Incomplete or Outdated Certificates

Expired, improperly issued or incorrectly legalized documents can prevent the authority from validating the file.

Weak Stability or Quality Evidence

Generic reports that do not identify the submitted product, formulation or packaging may be insufficient.

Artwork Submitted Too Early

Final artwork prepared before classification and dossier validation may require costly redesign.

Poor Query Responses

Uploading additional documents without addressing the authority’s exact concern can create repeated review cycles.

How Long Does EDE Product Registration Take?

There is no single reliable timeframe for every EDE application.

EDE currently publishes a service-completion duration of 45 working days for several marketing-authorization services, including:

  • Drug and biopharmaceutical products

  • Healthcare products

  • Medical devices

This published service duration should not be interpreted as a guaranteed total project timeline.

Overall readiness may also depend on:

  • Product classification

  • Applicant and manufacturer registration

  • Dossier preparation

  • Document legalization

  • Authority queries

  • Laboratory analysis

  • Pricing or pharmacovigilance requirements

  • Correction of deficiencies

  • Committee review

  • Applicant response time

Businesses should plan from the beginning of regulatory preparation rather than counting only the authority-review stage.

How Long Is an EDE Marketing Authorization Valid?

EDE’s current service information states that several medical-product marketing authorizations are issued with a five-year validity, although a different period may be granted where applicable.

The authorization itself should be checked for:

  • Issue date

  • Expiry date

  • Renewal conditions

  • Approved product scope

  • Applicable restrictions

Renewal preparation should begin before expiry because updated certificates, artwork, product information and change records may be required.

Post-Authorization Compliance

Marketing authorization does not end the regulatory responsibility.

Businesses may need to manage:

  • Product renewals

  • Formula or composition changes

  • Manufacturer changes

  • Manufacturing-site changes

  • Label and leaflet updates

  • New pack sizes or device models

  • Safety reporting

  • Pharmacovigilance

  • Post-market surveillance

  • Product complaints

  • Recall and traceability obligations

  • Advertising approval

  • Authority inspections

Changes should be assessed before implementation. Depending on their significance, they may require notification, a variation application or a new authorization.

What EDE Marketing Authorization Does Not Replace

An EDE marketing authorization does not automatically replace:

  • The company’s trade licence

  • Establishment or warehouse licensing

  • Import permits

  • Customs procedures

  • Consignment release

  • Product pricing requirements where applicable

  • Advertising approval

  • Municipality or emirate-specific obligations

  • Approval in another GCC country

Each commercial and regulatory requirement should be confirmed separately.

MOHAP Product Registration UAE FAQ

  • Is MOHAP Still the Registration Authority for Medical Products?

Medical-product classification and marketing-authorization services within the federal medical-products framework are currently provided through the Emirates Drug Establishment.

“MOHAP product registration” remains a common legacy search term, but applicants should use the current EDE service and requirements.

  • Is EDE the Same as MOHAP?

No. EDE is a separate federal regulatory entity established under Federal Decree-Law No. 28 of 2023.

  • Do All Supplements Require EDE Registration?

No. The correct authority depends on the supplement’s composition, dosage form, intended use, presentation and claims.

Classification should be confirmed before submission.

  • Can a Foreign Manufacturer Apply Directly?

Eligibility depends on the service. Marketing-authorization applications generally require an accepted UAE applicant structure, while the classification service is available to a broader range of applicants.

  • Is Medical-Product Classification the Same as Registration?

No. Classification identifies the applicable regulatory category and whether marketing authorization is required. It does not itself authorize commercial sale.

  • Is Every EDE Authorization Valid for Five Years?

Several EDE marketing-authorization services state a five-year validity, although EDE may grant another validity period where applicable. The issued authorization remains the controlling document.

  • Does EDE Approval Allow Sale Across the GCC?

No. Approval in the UAE does not automatically replace the registration and market-entry requirements of other GCC countries.

  • Must the Product Be Registered Before Advertising?

Medical-product advertising is separately regulated. A valid marketing authorization and specific advertising approval may be required according to the product and promotional activity.

How Product Registration UAE Can Support EDE Readiness

Product Registration UAE can assist within the agreed service scope through:

  • Medical-product classification assessment

  • Regulatory-pathway confirmation

  • Applicant and manufacturing-site readiness review

  • Formula and ingredient assessment

  • Medical-device documentation review

  • Dossier-gap analysis

  • Label and artwork validation

  • Arabic regulatory translation support

  • Certificate and technical-document review

  • Submission preparation and coordination

  • Authority-query support

  • Variation and renewal readiness

  • Alignment between authorization records and the commercial product

The Emirates Drug Establishment independently reviews applications and makes the final regulatory decision.

Final Takeaway

MOHAP product registration UAE is now best understood as a legacy search term for medical-product regulatory processes currently administered through EDE.

Businesses should not begin with a generic document checklist.

They should first confirm product classification, applicant eligibility, manufacturing-site readiness and the correct EDE marketing-authorization route. The technical dossier, label, evidence and post-market controls can then be prepared for the actual product category.

Contact Product Registration UAE or use the website chatbot to discuss the classification and regulatory pathway applicable to your medical, healthcare or device product.

Related Medical-Product Compliance Insights

Explore Further: Read Related Articles